These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 7060034

  • 1. Multiple myeloma resistant to melphalan: treatment with doxorubicin, cyclophosphamide, carmustine (BCNU), and prednisone.
    Kyle RA, Pajak TF, Henderson ES, Nawabi IU, Brunner K, Henry PH, McIntyre OR, Holland JF.
    Cancer Treat Rep; 1982 Mar; 66(3):451-6. PubMed ID: 7060034
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Therapy for multiple myeloma with alternating non-cross-resistant chemotherapy combinations: heterogeneity of tumor responsiveness.
    Morstyn G, Schechter GP, Ihde DC, Carney DN, Eddy JL, Cohen MH, Minna JD, Bunn PA.
    Cancer Treat Rep; 1984 Dec; 68(12):1439-46. PubMed ID: 6391662
    [Abstract] [Full Text] [Related]

  • 10. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
    Oken MM, Leong T, Lenhard RE, Greipp PR, Kay NE, Van Ness B, Keimowitz RM, Kyle RA.
    Cancer; 1999 Sep 15; 86(6):957-68. PubMed ID: 10491521
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Polychemotherapy in multiple myeloma. The COMPA protocol].
    Vázquez-Villegas V, Delgado Lamas JL, Romero-García F, Rodríguez-Carrillo J, Medina-Ruiz F.
    Rev Invest Clin; 1989 Sep 15; 41(4):345-50. PubMed ID: 2698501
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Remission maintenance therapy for multiple myeloma.
    Arch Intern Med; 1975 Jan 15; 135(1):147-52. PubMed ID: 1111463
    [Abstract] [Full Text] [Related]

  • 19. Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
    Van Dobbenburgh OA, Houwen B, Piersma H, Marrink J, Ockhuizen T, Halie MR, Nieweg HO.
    Neth J Med; 1984 Jan 15; 27(2):25-30. PubMed ID: 6709108
    [No Abstract] [Full Text] [Related]

  • 20. Multiple myeloma: results with the M-2 protocol in a community hospital.
    Miller S, Perrotta AL.
    J Am Osteopath Assoc; 1979 Aug 15; 78(12):857-64. PubMed ID: 489428
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.